Specialty Pharmacy

As senior vice president of global marketing and strategic alliance management, Ed Cinca will lead worldwide commercial strategy for the entire Currax portfolio, including brand and generic medications.

Uplizna is used to treat adults with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 (AQP4) antibody positive.

John Ortner was named senior vice president of finance and chief administration officer; Micaila Ruiz is now senior vice president, COO and chief pharmacy officer; and Julie Zatizabal was appointed chief revenue officer.

FSD Pharma has entered into an agreement with Covar Pharmaceuticals to commence work on providing research quantities of FSD’s drug candidate, Lucid-PSYCH.

Skytrofa is the first and only FDA-approved, once-weekly treatment for pediatric growth hormone deficiency.

Tavneos is used as an adjunctive treatment of adult patients with severe active ANCA-associated vasculitis, in combination with standard therapy.

Specialty pharmacy provides customers with a wide range of services, including in-depth monitoring and patient counseling, as well as reimbursement assistance.

Innovative offerings from The Compliance Team, Knapp, LexisNexis Risk Solutions and Surescripts are available to help specialty retailers.